Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ron, in case of a marketing campain

John....Ron

in response to by
posted on Aug 08, 2007 10:46AM

The hurdle of not having any marketable, mega-million dolllar revenue-producing product over the last seven years, nor at present, will not likely be cured prior to January 2008 --- which is when the "life-threatening" event occurs.

I do agree with you on the time line. I would suggest that PTSC indeed has "something" going on, but we don't have a clue as to the relative success. It is all part of the great PTSC unknown and that is what might attract a risk taker. However, my guess is we already have a pile of risk takers just waiting for the reward part or the equation to materialize. Thus, the low volume and high trepidation rates we see regarding PTSC's future.

For me, it's a penny stock and I know the risk. Heck, I've owned EDIG since 1999 and still buy a little more here and there. That makes me a glutton for punishment, just plain ole big dumb guy from Tennessee, or a risk taker.

Here's wishin' the tea leaves were a bit clearer...

John

Share
New Message
Please login to post a reply